Reduced Gastric Mucosal Innervation in Obesity: A Biomarker Predicting Remission of Diabetes After Bariatric Surgery
Obesity · 2025
DOI: 10.1002/oby.70012 ↗At a glance
Journal article in Obesity, 2025. Written by Po-Jen Yang and 11 co-authors. Institution: Department of Surgery, National Taiwan University Hospital, Taipei, Taiwan. Major MEDLINE topics: Diabetes Mellitus, Type 2, Gastric Mucosa, Bariatric Surgery, Obesity. Cited 1 times so far (Crossref); 36 references. Funded by: National Taiwan University Hospital, Taiwan Health Foundation, Ministry of Science and Technology, Taiwan.
Topics: Diabetes mellitus
Abstract (original language)
Objective
Obesity is a risk factor for dysregulated gastric function and peripheral nerve degeneration. This study aimed to investigate the impact of obesity on the structural pathology and morphometry of gastric mucosal innervation.
Methods
Sixty patients with obesity (30 with and 30 without type 2 diabetes) undergoing sleeve gastrectomy and 15 healthy controls were recruited. Gastric mucosal nerve terminals at the antrum were immunostained using protein gene product 9.5 and quantified using stereology‐based morphometry to determine gastric mucosal innervation density (GMID).
Results
Patients with obesity had lower GMID than control participants (464.0 ± 157.5 vs. 789.7 ± 188.9 mm/mm 3 , p < 0.001). There was a further reduction in GMID in patients with diabetes than in those without diabetes (406.8 ± 113.9 vs. 521.2 ± 175.3 mm/mm 3 , p < 0.001). GMID was significantly associated with BMI and glycemic parameters (fasting blood glucose, HbA1c) in multilinear regression analyses. One year post surgery, 19 patients achieving diabetes remission showed higher GMID compared to those without remission (444.8 ± 111.5 mm/mm 3 vs. 341.1 ± 88.1 mm/mm 3 , p = 0.012). GMID remained an independent predictor for diabetes remission in multivariable logistic regression analyses.
Conclusions
Gastric mucosal innervation was significantly reduced by the synergistic effects of obesity and diabetes. GMID could serve as a potential biomarker for predicting diabetes remission following bariatric surgery.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Surgery, National Taiwan University Hospital, Taipei, Taiwan.
- Center for Obesity, Life Style, and Metabolic Surgery, National Taiwan University Hospital, Taipei, Taiwan.
- Department of Surgery, College of Medicine, National Taiwan University, Taipei, Taiwan.
- Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
- Department of Pathology, National Taiwan University Hospital, Taipei, Taiwan.
- Department of Forensic Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan.
ORCID profiles: Po-Jen Yang
Funding
- National Taiwan University Hospital
- Taiwan Health Foundation
- Ministry of Science and Technology, Taiwan
- National Science and Technology Council
Cite
APA
Yang, P. J., Tseng, P. H., Chang, K., Chao, C. C., Wei, J. J., Yang, W. S., Chen, C. L., Ke, H. F., Lee, P. C., Chen, C. N., Lin, M. T., & Hsieh, S. T. (2025). Reduced Gastric Mucosal Innervation in Obesity: A Biomarker Predicting Remission of Diabetes After Bariatric Surgery. Obesity. https://doi.org/10.1002/oby.70012
Vancouver
Yang PJ, Tseng PH, Chang K, Chao CC, Wei JJ, Yang WS, et al. Reduced Gastric Mucosal Innervation in Obesity: A Biomarker Predicting Remission of Diabetes After Bariatric Surgery. Obesity. 2025. doi:10.1002/oby.70012
BibTeX
@article{Yang2025,
author = {Yang, Po-Jen and Tseng, Ping-Huei and Chang, Koping and Chao, Chi-Chao and Wei, Jing-Jung and Yang, Wei-Shiung and Chen, Chi-Ling and Ke, Hui-Fang and Lee, Po-Chu and Chen, Chiung-Nien and Lin, Ming-Tsan and Hsieh, Sung-Tsang},
title = {Reduced Gastric Mucosal Innervation in Obesity: A Biomarker Predicting Remission of Diabetes After Bariatric Surgery},
journal = {Obesity},
year = {2025},
doi = {10.1002/oby.70012}
}
EUVIMED